At JMP Securities, our investment bankers concentrate on four industries—technology, healthcare, financial services, and real estate.
Our success depends on our ability to evaluate and structure transactions that create long-term shareholder value, and a successful transaction requires us to draw on all of our strengths: exceptional client focus, in-depth industry knowledge, and skilled execution. We are especially proud of our tendency to build lasting relationships with our clients, playing a true advisory role and working on multiple transactions over time.
Our capital raising capabilities include public and private capital markets transactions, including equity, debt, and convertible securities offerings. We also offer a broad range of strategic advisory services, such as mergers and acquisitions, divestitures, recapitalizations, and valuations and fairness opinions. In addition, we provide restructuring services, including liability management, debt restructuring, sourcing of new debt and equity capital, asset sales, reorganizations, and distressed M&A.
Co-Head of Investment Banking
Head of Financial Services & Real Estate Investment Banking
Jon Dever is a Managing Director and is co-head of investment banking at JMP Securities. He also serves as head of financial services and real estate investment banking. In addition, Jon is a member of the executive committee of JMP Group.
Prior to joining JMP, Jon was a Managing Director in the investment banking division at Lehman Brothers, working with finance companies and depositories. Jon previously served as an Executive Director in the financial services group at UBS and spent eight years in investment banking at PaineWebber before its acquisition by UBS in 2000. During his career, he has worked with banks, thrifts and non-bank financial institutions, including mortgage lenders, consumer finance companies, commercial finance companies and specialty lenders such as business development companies and REITs.
Jon holds a BA from Georgetown University.
Gavin Slader is a Managing Director and is co-head of investment banking at JMP Securities. He also serves as head of mergers and acquisitions. In addition, Gavin is a member of the executive committee of JMP Group.
Prior to joining JMP, Gavin was a senior banker in the technology, media and telecommunications investment banking group at UBS Investment Bank, sharing oversight of the west coast technology mergers and acquisitions practice. Gavin previously held investment banking roles at Piper Jaffray & Co., Credit Suisse First Boston, and Donaldson, Lufkin & Jenrette, concentrating on mergers and acquisitions throughout. He began his Wall Street career in Deutsche Bank’s leveraged finance group.
Gavin holds a BA from Claremont McKenna College, graduating with dual degrees in economics and accounting.
Thomas Kilian is Chief Operating Officer of JMP Securities’ investment banking department and a Managing Director in its financial services investment banking group. He also served as Chief Financial Officer of JMP Group from July 2004 until April 2010, a period that included the company’s IPO in May 2007.
Thomas has been at JMP since its inception in 1999. While at JMP, Thomas has worked with non-bank financial institutions in the broker-dealer, commercial finance, consumer finance, insurance and mortgage sectors and has completed more than 100 capital raising transactions and strategic advisory assignments. Prior to joining JMP, Thomas was at NationsBanc Montgomery Securities, now Banc of America Securities, in the financial services group, focusing on corporate finance. From 1992 until 1996, Thomas served in Deutsche Bank’s corporate development group in Frankfurt, Germany, focusing on strategic planning and business development.
Thomas holds an MBA from Stanford University and a Master’s degree in industrial engineering from Karlsruhe University, Germany.
David Kellman is a Managing Director and is head of healthcare investment banking at JMP Securities. He serves on the firm’s investment banking management committee.
Prior to joining JMP, David was a Vice President at Paramount BioSciences, a life sciences investment firm. Previously, he was a hedge fund analyst at S.A.C. Capital Advisors focused on healthcare investing and a member of the healthcare investment banking group at Piper Jaffray. David began his career in the healthcare group of Investor Growth Capital, the venture capital arm of Investor AB.
David holds a BS in finance from the University of Pennsylvania’s Wharton School and a BSE in bioengineering from its School of Engineering and Applied Science.
Kevin McClelland is a Managing Director and is head of technology investment banking at JMP Securities. He serves on the firm’s investment banking management committee.
Prior to joining JMP, Kevin was Principal at Broadview International, a technology-focused M&A advisory firm, where he led the firm’s west coast infrastructure software M&A practice and completed more than 30 transactions, including buy-side and sell-side advisory engagements, divestitures, private placements and strategic advisory assignments. Kevin previously worked for Andersen Consulting, now Accenture, designing and implementing custom and off-the-shelf software applications.
Kevin holds an MBA from Harvard Business School, a BS in electrical engineering from the University of Illinois and a BA from Wheaton College.
Alfredo Barreto, Jr. is a Managing Director in JMP Securities’ investment banking group focused on the cannabis industry.
Prior to joining JMP Securities, Alfredo was a partner at Wood Warren & Co., a Bay Area boutique investment bank serving the food, beverage, and agriculture industries. He was previously a Managing Director leading financial sponsor coverage at The Silverfern Group, after serving as co-head of West Coast consumer and retail investment banking at J.P. Morgan Securities. He began his Wall Street career as a member of the mergers and acquisitions group and the global retail coverage group at Morgan Stanley & Co.
Alfredo holds an MBA from the Kellogg School of Management at Northwestern University and a BA from Columbia University.
Fedora Baloiu is a Managing Director in JMP Securities’ healthcare investment banking group and serves as co-head of biopharma corporate finance.
Prior to joining JMP, Fedora was a Managing Director and head of U.S. healthcare investment banking at Nomura Securities. She previously served as head of the biopharmaceuticals practice at Houlihan Lokey, after spending nearly a decade in the healthcare investment banking division at Goldman Sachs & Co. She began her career as a consultant at Bain & Company in Milan, Italy.
Fedora holds a master’s degree in biotechnology from Johns Hopkins University, an MBA from Columbia Business School, and an undergraduate business degree from Italy’s Bocconi University.
Tosh Chandra is a Managing Director in JMP Securities’ financial services investment banking group focused on commercial and mortgage finance.
Prior to joining JMP, Tosh was a proprietary market maker for Gotham Investment Management in Gold Options on the COMEX division of the NYMEX. He was previously a venture capital associate at Riverside Management Group and began his career at PaineWebber Incorporated in the investment banking division’s financial institutions group.
Tosh holds an MBA from the McDonough School of Business at Georgetown University and a BA from Duke University.
Bard Cook is a Managing Director and is head of debt markets and advisory at JMP Securities.
Bard has over 30 years of experience assisting corporate issuers in accessing the capital markets for a wide range of debt instruments, including public/Rule 144A investment grade and high yield bonds, hybrid capital securities, private senior and subordinated notes, institutional leveraged loans, syndicated and club lending facilities, and asset backed securities.
Prior to joining JMP, Bard was a Managing Director at RBC Capital Markets, where he established its U.S. corporate debt business and during his tenure was responsible for the firm’s high yield, private placement and investment grade debt capital markets groups. He previously ran Mellon Bank’s placement division and held several positions in corporate banking.
Bard holds a BA from Yale University.
Ken Clausman is a Managing Director in the equity capital markets group at JMP Securities.
Prior to joining JMP, Ken was a Director in equity capital markets at Cowen and Company, where he concentrated on the origination and execution of transactions in the life sciences and technology sectors. He previously served in investment banking roles at Cantor Fitzgerald & Co., Waller Capital Partners and Veronis Suhler Stevenson Partners.
Ken holds a BBA from Loyola University Maryland.
Raj Dayalan is a Managing Director in JMP Securities’ technology investment banking group with a focus on Internet and software.
Prior to joining JMP, Raj was a Managing Director at Rothschild & Co. concentrating on technology subsectors such as mobile payments, marketing technology, and software-as-a-service. Raj was previously at Houlihan Lokey, where he served as co-head of Internet and related software investment banking, and at UBS Investment Bank, where he served as co-head of Internet and payments investment banking. Earlier in his career, Raj held business development roles in mobile technology and healthcare informatics, after working in technology investment banking at both Deutsche Bank Securities and Salomon Brothers.
Raj holds an MBA from the UCLA Anderson School of Management and a BA from University of California, Irvine.
Carin Fradin is a Managing Director in JMP Securities’ healthcare investment banking group and serves as head of medical devices and diagnostics investment banking.
Prior to joining JMP, Carin was a Managing Director at Four Oaks Partners, a transaction advisory firm serving the life sciences industry, where she focused on the medical device space. She was previously a Managing Director and senior advisor at boutique investment bank Sagent Advisors. Carin also spent 12 years in healthcare investment banking at UBS Investment Bank, most recently as a Managing Director, concentrating on the medical device and medical technology industries. For approximately half of her tenure at the firm, Carin additionally led the U.S. execution of all cross-border medical technology transactions originated in Asia.
Carin holds a BA in mathematics and psychology from the University of Pennsylvania.
Forrest Koenig is a Managing Director in JMP Securities’ investment banking group and is head of convertible and equity-linked capital markets.
Prior to joining JMP, Forrest was a Managing Director in the equity-linked origination group at Piper Jaffray, focusing on the origination and structuring of convertible and equity-linked securities offerings. Forrest started at Piper Jaffray as a quantitative risk analyst on the convertible sales and trading desk, where he concentrated on valuation, modeling and credit analysis. He began his Wall Street career at Citigroup Smith Barney.
Forrest holds a BA in economics with minors in math and physics from the University of California, San Diego. He is a chartered financial analyst.
Andy Mertz is a Managing Director and head of equity capital markets at JMP Securities.
Prior to joining JMP, Andy was a Managing Director in equity capital markets at Cowen and Company, where he oversaw equity financing activity in the technology and healthcare verticals and, earlier in his career, served as head of equity syndicate. He previously held equity capital markets positions at Robertson Stephens and Bear, Stearns & Co.
Andy holds an MBA from Fordham University and a BBA from Pace University.
Jay Magee is a Managing Director in JMP Securities’ financial services investment banking group. His areas of focus include auto, consumer, commercial and mortgage finance as well as technology-enabled financial services.
Since joining JMP, Jay has completed nearly 100 middle-market transactions—including public debt and equity financings, private placements, and strategic advisory assignments—with an aggregate consideration of more than $19 billion. Prior to joining JMP, Jay worked in the real estate merchant banking group at Wells Fargo and in the private client group at Merrill Lynch.
Jay holds an MBA from the McDonough School of Business at Georgetown University and a BA from Villanova University.
David Schechner is a Managing Director in JMP Securities’ healthcare investment banking group and serves as head of biopharma mergers and acquisitions.
Prior to joining JMP, David led biotechnology, pharmaceutical, and pharmaceutical services investment banking at Robert W. Baird & Co. He was previously head of the pharmaceuticals investment banking group at Canaccord Genuity, after founding and leading the biotechnology investment banking group at Needham & Company. He also held senior investment banking roles at Goldman Sachs and Bear Stearns, focusing on healthcare and technology.
David holds an MBA from Harvard Business School and a BA from Cornell University.
Jorge Solares-Parkhurst is a Managing Director in JMP Securities’ financial services investment banking group.
Prior to joining JMP, Jorge had been a Director in the global financial institutions group at Credit Suisse, where he worked with U.S. specialty lenders and regional banks. He previously served as a Managing Director at FBR Capital Markets and a Senior Managing Director at Bear, Stearns & Co. Jorge began his career in PaineWebber’s investment banking division, remaining with the firm following its acquisition by UBS and concluding his tenure there as a Director in the financial institutions group for the Americas.
Jorge holds a BSFS in international economics from The Edmund A. Walsh School of Foreign Service at Georgetown University.
Alan Tekerlek is a Managing Director in JMP Securities’ technology investment banking group.
Prior to joining JMP, Alan founded and was managing partner of Aspect Partners, a boutique merchant banking firm focused on advising and investing in middle-market companies in a broad range of industries. He was previously a senior member of the global technology group at Lehman Brothers, where he provided capital markets and strategic advisory services to corporate clients in the software and Internet and digital media sectors, among others. Earlier in his career, Alan worked in corporate finance and restructuring at GE Capital Corporation and in strategy consulting at Theodore Barry & Associates.
Alan holds a BA from University of California, Los Angeles.
Elgin Thompson is a Managing Director in JMP Securities’ technology investment banking group with a focus on the Internet and digital media.
Prior to joining JMP, Elgin was a Managing Director at Digital Capital Advisors, an advisory boutique focused on emerging technology companies. Elgin previously served as Senior Vice President of Strategy and Corporate Development at GridNetworks, a venture-backed Internet infrastructure provider, where he was instrumental in negotiating the company’s sale. Earlier in his career, he was a senior member of the technology and media investment banking groups at Bear Stearns and Merrill Lynch and practiced mergers and acquisitions law with DLA Piper and Wildman Harold (now Lord & Locke).
Elgin holds an MBA from the Kellogg School of Management at Northwestern University, a JD from Temple University Beasley School of Law, and a BA from Northern Illinois University.